Ayse Mavi, Tevfik F Cermik, Muammer Urhan, Halis Puskulcu, Sandip Basu, Jian Q Yu, Hongming Zhuang, Brian Czerniecki, Abass Alavi. J Nucl Med 2007
Times Cited: 63
Times Cited: 63
Times Cited
Times Co-cited
Similarity
Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Sandip Basu, Wengen Chen, Julia Tchou, Ayse Mavi, Tevfik Cermik, Brian Czerniecki, Mitchell Schnall, Abass Alavi. Cancer 2008
Sandip Basu, Wengen Chen, Julia Tchou, Ayse Mavi, Tevfik Cermik, Brian Czerniecki, Mitchell Schnall, Abass Alavi. Cancer 2008
55
FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.
Andreas Buck, Holger Schirrmeister, Thorsten Kühn, Changxian Shen, Thomas Kalker, Jörg Kotzerke, Anja Dankerl, Gerhard Glatting, Sven Reske, Torsten Mattfeldt. Eur J Nucl Med Mol Imaging 2002
Andreas Buck, Holger Schirrmeister, Thorsten Kühn, Changxian Shen, Thomas Kalker, Jörg Kotzerke, Anja Dankerl, Gerhard Glatting, Sven Reske, Torsten Mattfeldt. Eur J Nucl Med Mol Imaging 2002
50
Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.
Shigeto Ueda, Hitoshi Tsuda, Hideki Asakawa, Takashi Shigekawa, Kazuhiko Fukatsu, Nobuo Kondo, Mikio Yamamoto, Yukihiro Hama, Katsumi Tamura, Jiro Ishida,[...]. Jpn J Clin Oncol 2008
Shigeto Ueda, Hitoshi Tsuda, Hideki Asakawa, Takashi Shigekawa, Kazuhiko Fukatsu, Nobuo Kondo, Mikio Yamamoto, Yukihiro Hama, Katsumi Tamura, Jiro Ishida,[...]. Jpn J Clin Oncol 2008
46
Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer.
David Groheux, Sylvie Giacchetti, Jean-Luc Moretti, Raphael Porcher, Marc Espié, Jacqueline Lehmann-Che, Anne de Roquancourt, Anne-Sophie Hamy, Caroline Cuvier, Laetitia Vercellino,[...]. Eur J Nucl Med Mol Imaging 2011
David Groheux, Sylvie Giacchetti, Jean-Luc Moretti, Raphael Porcher, Marc Espié, Jacqueline Lehmann-Che, Anne de Roquancourt, Anne-Sophie Hamy, Caroline Cuvier, Laetitia Vercellino,[...]. Eur J Nucl Med Mol Imaging 2011
42
Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.
N Avril, M Menzel, J Dose, M Schelling, W Weber, F Jänicke, W Nathrath, M Schwaiger. J Nucl Med 2001
N Avril, M Menzel, J Dose, M Schelling, W Weber, F Jänicke, W Nathrath, M Schwaiger. J Nucl Med 2001
41
18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysis.
Joseph R Osborne, Elisa Port, Mithat Gonen, Ashley Doane, Henry Yeung, William Gerald, Josh B Cook, Steven Larson. J Nucl Med 2010
Joseph R Osborne, Elisa Port, Mithat Gonen, Ashley Doane, Henry Yeung, William Gerald, Josh B Cook, Steven Larson. J Nucl Med 2010
41
Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer.
A Gil-Rendo, F Martínez-Regueira, G Zornoza, M J García-Velloso, C Beorlegui, N Rodriguez-Spiteri. Br J Surg 2009
A Gil-Rendo, F Martínez-Regueira, G Zornoza, M J García-Velloso, C Beorlegui, N Rodriguez-Spiteri. Br J Surg 2009
38
The relationship between FDG uptake in PET scans and biological behavior in breast cancer.
Wataru Shimoda, Mitsuhiro Hayashi, Koji Murakami, Tetsunari Oyama, Masakatsu Sunagawa. Breast Cancer 2007
Wataru Shimoda, Mitsuhiro Hayashi, Koji Murakami, Tetsunari Oyama, Masakatsu Sunagawa. Breast Cancer 2007
38
Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation.
F Crippa, E Seregni, R Agresti, C Chiesa, C Pascali, A Bogni, D Decise, V De Sanctis, M Greco, M G Daidone,[...]. Eur J Nucl Med 1998
F Crippa, E Seregni, R Agresti, C Chiesa, C Pascali, A Bogni, D Decise, V De Sanctis, M Greco, M G Daidone,[...]. Eur J Nucl Med 1998
34
Standardized uptake values for breast carcinomas assessed by fluorodeoxyglucose-positron emission tomography correlate with prognostic factors.
Naoki Ikenaga, Naoki Otomo, Atsushi Toyofuku, Yuji Ueda, Kiyokazu Toyoda, Tohru Hayashi, Kiyoshi Nishikawa, Masao Tanaka. Am Surg 2007
Naoki Ikenaga, Naoki Otomo, Atsushi Toyofuku, Yuji Ueda, Kiyokazu Toyoda, Tohru Hayashi, Kiyoshi Nishikawa, Masao Tanaka. Am Surg 2007
39
Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer.
Rakesh Kumar, Anil Chauhan, Hongming Zhuang, Prem Chandra, Mitchell Schnall, Abass Alavi. Breast Cancer Res Treat 2006
Rakesh Kumar, Anil Chauhan, Hongming Zhuang, Prem Chandra, Mitchell Schnall, Abass Alavi. Breast Cancer Res Treat 2006
28
[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy.
Alina Berriolo-Riedinger, Claude Touzery, Jean-Marc Riedinger, Michel Toubeau, Bruno Coudert, Laurent Arnould, Christophe Boichot, Alexandre Cochet, Pierre Fumoleau, François Brunotte. Eur J Nucl Med Mol Imaging 2007
Alina Berriolo-Riedinger, Claude Touzery, Jean-Marc Riedinger, Michel Toubeau, Bruno Coudert, Laurent Arnould, Christophe Boichot, Alexandre Cochet, Pierre Fumoleau, François Brunotte. Eur J Nucl Med Mol Imaging 2007
23
Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography.
Reinhard Bos, Jacobus J M van Der Hoeven, Elsken van Der Wall, Petra van Der Groep, Paul J van Diest, Emile F I Comans, Urvi Joshi, Gregg L Semenza, Otto S Hoekstra, Adriaan A Lammertsma,[...]. J Clin Oncol 2002
Reinhard Bos, Jacobus J M van Der Hoeven, Elsken van Der Wall, Petra van Der Groep, Paul J van Diest, Emile F I Comans, Urvi Joshi, Gregg L Semenza, Otto S Hoekstra, Adriaan A Lammertsma,[...]. J Clin Oncol 2002
23
Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations.
N Avril, C A Rosé, M Schelling, J Dose, W Kuhn, S Bense, W Weber, S Ziegler, H Graeff, M Schwaiger. J Clin Oncol 2000
N Avril, C A Rosé, M Schelling, J Dose, W Kuhn, S Bense, W Weber, S Ziegler, H Graeff, M Schwaiger. J Clin Oncol 2000
22
Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors.
Pierre Heudel, Sebastien Cimarelli, Anthony Montella, Catherine Bouteille, Thomas Mognetti. Int J Clin Oncol 2010
Pierre Heudel, Sebastien Cimarelli, Anthony Montella, Catherine Bouteille, Thomas Mognetti. Int J Clin Oncol 2010
24
Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes.
Ayse Mavi, Muammer Urhan, Jian Q Yu, Hongming Zhuang, Mohamed Houseni, Tevfik F Cermik, Dhurairaj Thiruvenkatasamy, Brian Czerniecki, Mitchell Schnall, Abass Alavi. J Nucl Med 2006
Ayse Mavi, Muammer Urhan, Jian Q Yu, Hongming Zhuang, Mohamed Houseni, Tevfik F Cermik, Dhurairaj Thiruvenkatasamy, Brian Czerniecki, Mitchell Schnall, Abass Alavi. J Nucl Med 2006
20
Biological characterisation of breast cancer by means of PET.
Andreas K Buck, Holger Schirrmeister, Torsten Mattfeldt, Sven N Reske. Eur J Nucl Med Mol Imaging 2004
Andreas K Buck, Holger Schirrmeister, Torsten Mattfeldt, Sven N Reske. Eur J Nucl Med Mol Imaging 2004
17
Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays.
F Dehdashti, J E Mortimer, B A Siegel, L K Griffeth, T J Bonasera, M J Fusselman, D D Detert, P D Cutler, J A Katzenellenbogen, M J Welch. J Nucl Med 1995
F Dehdashti, J E Mortimer, B A Siegel, L K Griffeth, T J Bonasera, M J Fusselman, D D Detert, P D Cutler, J A Katzenellenbogen, M J Welch. J Nucl Med 1995
15
Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.
David Fuster, Joan Duch, Pilar Paredes, Martín Velasco, Montserrat Muñoz, Gorane Santamaría, Montserrat Fontanillas, Francesca Pons. J Clin Oncol 2008
David Fuster, Joan Duch, Pilar Paredes, Martín Velasco, Montserrat Muñoz, Gorane Santamaría, Montserrat Fontanillas, Francesca Pons. J Clin Oncol 2008
14
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.
C W Elston, I O Ellis. Histopathology 1991
C W Elston, I O Ellis. Histopathology 1991
14
Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose.
M Oshida, K Uno, M Suzuki, T Nagashima, H Hashimoto, H Yagata, T Shishikura, K Imazeki, N Nakajima. Cancer 1998
M Oshida, K Uno, M Suzuki, T Nagashima, H Hashimoto, H Yagata, T Shishikura, K Imazeki, N Nakajima. Cancer 1998
14
Implications of standardized uptake value measurements of the primary lesions in proven cases of breast carcinoma with different degree of disease burden at diagnosis: does 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography predict tumor biology?
Sandip Basu, Ayse Mavi, Tevfik Cermik, Mohamed Houseni, Abass Alavi. Mol Imaging Biol 2008
Sandip Basu, Ayse Mavi, Tevfik Cermik, Mohamed Houseni, Abass Alavi. Mol Imaging Biol 2008
28
Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET.
Rakesh Kumar, Vilert A Loving, Anil Chauhan, Hongming Zhuang, Schnall Mitchell, Abass Alavi. J Nucl Med 2005
Rakesh Kumar, Vilert A Loving, Anil Chauhan, Hongming Zhuang, Schnall Mitchell, Abass Alavi. J Nucl Med 2005
12
Preoperative evaluation of prognosis in breast cancer patients by [(18)F]2-Deoxy-2-fluoro-D-glucose-positron emission tomography.
Tomoo Inoue, Kenji Yutani, Tetsuya Taguchi, Yasuhiro Tamaki, Eiichi Shiba, Shinzaburo Noguchi. J Cancer Res Clin Oncol 2004
Tomoo Inoue, Kenji Yutani, Tetsuya Taguchi, Yasuhiro Tamaki, Eiichi Shiba, Shinzaburo Noguchi. J Cancer Res Clin Oncol 2004
12
Usefulness of 18F-FDG uptake with clinicopathologic and immunohistochemical prognostic factors in breast cancer.
Bom Sahn Kim, Sun Hee Sung. Ann Nucl Med 2012
Bom Sahn Kim, Sun Hee Sung. Ann Nucl Med 2012
20
FDG PET, PET/CT, and breast cancer imaging.
Eric L Rosen, William B Eubank, David A Mankoff. Radiographics 2007
Eric L Rosen, William B Eubank, David A Mankoff. Radiographics 2007
11
High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer.
Wendie A Berg, Irving N Weinberg, Deepa Narayanan, Mary E Lobrano, Eric Ross, Laura Amodei, Lorraine Tafra, Lee P Adler, Joseph Uddo, William Stein,[...]. Breast J 2006
Wendie A Berg, Irving N Weinberg, Deepa Narayanan, Mary E Lobrano, Eric Ross, Laura Amodei, Lorraine Tafra, Lee P Adler, Joseph Uddo, William Stein,[...]. Breast J 2006
11
A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases.
U Veronesi, C De Cicco, V E Galimberti, J R Fernandez, N Rotmensz, G Viale, G Spano, A Luini, M Intra, P Veronesi,[...]. Ann Oncol 2007
U Veronesi, C De Cicco, V E Galimberti, J R Fernandez, N Rotmensz, G Viale, G Spano, A Luini, M Intra, P Veronesi,[...]. Ann Oncol 2007
11
Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer.
Tevfik F Cermik, Ayse Mavi, Sandip Basu, Abass Alavi. Eur J Nucl Med Mol Imaging 2008
Tevfik F Cermik, Ayse Mavi, Sandip Basu, Abass Alavi. Eur J Nucl Med Mol Imaging 2008
11
Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
11
FDG PET/CT and diffusion-weighted imaging for breast cancer: prognostic value of maximum standardized uptake values and apparent diffusion coefficient values of the primary lesion.
Masatoyo Nakajo, Yoriko Kajiya, Tomoyo Kaneko, Youichi Kaneko, Takashi Takasaki, Atsushi Tani, Masako Ueno, Chihaya Koriyama, Masayuki Nakajo. Eur J Nucl Med Mol Imaging 2010
Masatoyo Nakajo, Yoriko Kajiya, Tomoyo Kaneko, Youichi Kaneko, Takashi Takasaki, Atsushi Tani, Masako Ueno, Chihaya Koriyama, Masayuki Nakajo. Eur J Nucl Med Mol Imaging 2010
11
Performance of FDG PET/CT in the clinical management of breast cancer.
David Groheux, Marc Espié, Sylvie Giacchetti, Elif Hindié. Radiology 2013
David Groheux, Marc Espié, Sylvie Giacchetti, Elif Hindié. Radiology 2013
11
18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes.
Hye Ryoung Koo, Jeong Seon Park, Keon Wook Kang, Nariya Cho, Jung Min Chang, Min Sun Bae, Won Hwa Kim, Su Hyun Lee, Mi Young Kim, Jin You Kim,[...]. Eur Radiol 2014
Hye Ryoung Koo, Jeong Seon Park, Keon Wook Kang, Nariya Cho, Jung Min Chang, Min Sun Bae, Won Hwa Kim, Su Hyun Lee, Mi Young Kim, Jin You Kim,[...]. Eur Radiol 2014
11
Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group.
Richard L Wahl, Barry A Siegel, R Edward Coleman, Constantine G Gatsonis. J Clin Oncol 2004
Richard L Wahl, Barry A Siegel, R Edward Coleman, Constantine G Gatsonis. J Clin Oncol 2004
9
Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data.
Selin Carkaci, Homer A Macapinlac, Massimo Cristofanilli, Osama Mawlawi, Eric Rohren, Ana M Gonzalez Angulo, Shaheenah Dawood, Erika Resetkova, Huong T Le-Petross, Wei-Tse Yang. J Nucl Med 2009
Selin Carkaci, Homer A Macapinlac, Massimo Cristofanilli, Osama Mawlawi, Eric Rohren, Ana M Gonzalez Angulo, Shaheenah Dawood, Erika Resetkova, Huong T Le-Petross, Wei-Tse Yang. J Nucl Med 2009
9
Effect of (18)F-FDG PET/CT imaging in patients with clinical Stage II and III breast cancer.
David Groheux, Jean-Luc Moretti, Georges Baillet, Marc Espie, Sylvie Giacchetti, Elif Hindie, Christophe Hennequin, Jacques-Robert Vilcoq, Caroline Cuvier, Marie-Elisabeth Toubert,[...]. Int J Radiat Oncol Biol Phys 2008
David Groheux, Jean-Luc Moretti, Georges Baillet, Marc Espie, Sylvie Giacchetti, Elif Hindie, Christophe Hennequin, Jacques-Robert Vilcoq, Caroline Cuvier, Marie-Elisabeth Toubert,[...]. Int J Radiat Oncol Biol Phys 2008
9
Metabolic flare: indicator of hormone responsiveness in advanced breast cancer.
J E Mortimer, F Dehdashti, B A Siegel, K Trinkaus, J A Katzenellenbogen, M J Welch. J Clin Oncol 2001
J E Mortimer, F Dehdashti, B A Siegel, K Trinkaus, J A Katzenellenbogen, M J Welch. J Clin Oncol 2001
9
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
9
Increased FDG uptake in breast cancer is associated with prognostic factors.
Yasemin Sanli, Serkan Kuyumcu, Zeynep Gozde Ozkan, Göknur Işik, Hasan Karanlik, Burcu Guzelbey, Cuneyt Turkmen, Sevda Ozel, Ekrem Yavuz, Ayse Mudun. Ann Nucl Med 2012
Yasemin Sanli, Serkan Kuyumcu, Zeynep Gozde Ozkan, Göknur Işik, Hasan Karanlik, Burcu Guzelbey, Cuneyt Turkmen, Sevda Ozel, Ekrem Yavuz, Ayse Mudun. Ann Nucl Med 2012
12
Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer.
Hannah M Linden, Svetlana A Stekhova, Jeanne M Link, Julie R Gralow, Robert B Livingston, Georgiana K Ellis, Philip H Petra, Lanell M Peterson, Erin K Schubert, Lisa K Dunnwald,[...]. J Clin Oncol 2006
Hannah M Linden, Svetlana A Stekhova, Jeanne M Link, Julie R Gralow, Robert B Livingston, Georgiana K Ellis, Philip H Petra, Lanell M Peterson, Erin K Schubert, Lisa K Dunnwald,[...]. J Clin Oncol 2006
7
Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.
F Crippa, R Agresti, E Seregni, M Greco, C Pascali, A Bogni, C Chiesa, V De Sanctis, V Delledonne, B Salvadori,[...]. J Nucl Med 1998
F Crippa, R Agresti, E Seregni, M Greco, C Pascali, A Bogni, C Chiesa, V De Sanctis, V Delledonne, B Salvadori,[...]. J Nucl Med 1998
7
Dual time point FDG-PET/CT imaging... Potential tool for diagnosis of breast cancer.
A A Zytoon, K Murakami, M R El-Kholy, E El-Shorbagy. Clin Radiol 2008
A A Zytoon, K Murakami, M R El-Kholy, E El-Shorbagy. Clin Radiol 2008
12
Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose.
Jörg Schwarz-Dose, Michael Untch, Reinhold Tiling, Stefanie Sassen, Sven Mahner, Steffen Kahlert, Nadia Harbeck, Annette Lebeau, Winfried Brenner, Markus Schwaiger,[...]. J Clin Oncol 2009
Jörg Schwarz-Dose, Michael Untch, Reinhold Tiling, Stefanie Sassen, Sven Mahner, Steffen Kahlert, Nadia Harbeck, Annette Lebeau, Winfried Brenner, Markus Schwaiger,[...]. J Clin Oncol 2009
7
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.
D J Slamon, G M Clark, S G Wong, W J Levin, A Ullrich, W L McGuire. Science 1987
D J Slamon, G M Clark, S G Wong, W J Levin, A Ullrich, W L McGuire. Science 1987
7
18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer.
Jean-Louis Alberini, Florence Lerebours, Myriam Wartski, Emmanuelle Fourme, Elise Le Stanc, E Gontier, O Madar, P Cherel, A P Pecking. Cancer 2009
Jean-Louis Alberini, Florence Lerebours, Myriam Wartski, Emmanuelle Fourme, Elise Le Stanc, E Gontier, O Madar, P Cherel, A P Pecking. Cancer 2009
7
The evolving role of PET/CT in breast cancer.
David Groheux, Sylvie Giacchetti, Domenico Rubello, Adil Al-Nahhas, Jean-Luc Moretti, Marc Espié, Elif Hindié. Nucl Med Commun 2010
David Groheux, Sylvie Giacchetti, Domenico Rubello, Adil Al-Nahhas, Jean-Luc Moretti, Marc Espié, Elif Hindié. Nucl Med Commun 2010
45
Comparison of FDG PET and MRI for evaluating the tumor extent of breast cancer and the impact of FDG PET on the systemic staging and prognosis of patients who are candidates for breast-conserving therapy.
Takayoshi Uematsu, Masako Kasami, Sachiko Yuen. Breast Cancer 2009
Takayoshi Uematsu, Masako Kasami, Sachiko Yuen. Breast Cancer 2009
18
Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011.
A Goldhirsch, W C Wood, A S Coates, R D Gelber, B Thürlimann, H-J Senn. Ann Oncol 2011
A Goldhirsch, W C Wood, A S Coates, R D Gelber, B Thürlimann, H-J Senn. Ann Oncol 2011
7
Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy.
B B Koolen, M J T F D Vrancken Peeters, J Wesseling, E H Lips, W V Vogel, T S Aukema, E van Werkhoven, K G A Gilhuijs, S Rodenhuis, E J Th Rutgers,[...]. Eur J Nucl Med Mol Imaging 2012
B B Koolen, M J T F D Vrancken Peeters, J Wesseling, E H Lips, W V Vogel, T S Aukema, E van Werkhoven, K G A Gilhuijs, S Rodenhuis, E J Th Rutgers,[...]. Eur J Nucl Med Mol Imaging 2012
7
18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer.
Bong-Il Song, Sang-Woo Lee, Shin Young Jeong, Yee Soo Chae, Won Kee Lee, Byeong-Cheol Ahn, Jaetae Lee. J Nucl Med 2012
Bong-Il Song, Sang-Woo Lee, Shin Young Jeong, Yee Soo Chae, Won Kee Lee, Byeong-Cheol Ahn, Jaetae Lee. J Nucl Med 2012
8
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.